OverviewChartNews
Derivatives
TraderScreen

BAVARIAN NOR NAM. DK 10/  DK0015998017  /

Stuttgart
04/06/2024  14:23:44 Chg. -0.460 Volume Bid18:55:38 Ask18:55:38 High Low
24.260EUR -1.86% -
Turnover: -		 24.170Bid Size: 200 24.520Ask Size: 200 24.930 24.250
GlobeNewswire 31/05 Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Sm...
GlobeNewswire 29/04 Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chiku...
GlobeNewswire 02/04 Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
GlobeNewswire 23/02 Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines...
TeleTrader 19/08/2022 EU makes monkeypox vaccine more available
TeleTrader 18/08/2022 WH announces new strategies against monkeypox
TeleTrader 30/07/2022 Spain confirms second monkeypox death
TeleTrader 29/07/2022 Spain confirms Europe's first monkeypox death
TeleTrader 25/07/2022 Monkeypox vaccine approved by EU
TeleTrader 22/07/2022 EMA gives preliminary approval to monkeypox jab
GlobeNewswire 21/03/2022 Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Com...
GlobeNewswire 28/02/2022 Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead...
GlobeNewswire 14/02/2022 Bavarian Nordic Announces Breakthrough Therapy Designation for its RSV Vaccine Candidate for the Pre...
GlobeNewswire 06/12/2021 Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening it...
GlobeNewswire 05/12/2021 Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate
GlobeNewswire 01/09/2021 Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine Candidate
GlobeNewswire 23/08/2021 Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of CO...
GlobeNewswire 23/08/2021 Bavarian Nordic Initiates Phase 2 Clinical Trial of COVID-19 Booster Vaccine
GlobeNewswire 09/08/2021 Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine
GlobeNewswire 11/06/2021 Bavarian Nordic Assists Public Health England in Response to New Cases of Monkeypox
GlobeNewswire 08/03/2021 Bavarian Nordic Reports Encouraging Preclinical Data for COVID-19 Vaccine Candidate Ahead of First-i...
GlobeNewswire 16/12/2020 Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. Government
GlobeNewswire 24/08/2020 Bavarian Nordic Announces Positive Topline Results from Phase 3 Clinical Study of Freeze-dried Small...
GlobeNewswire 22/07/2020 Bavarian Nordic and AdaptVac Sign Final License Agreement on COVID-19 Vaccine
GlobeNewswire 01/07/2020 Bavarian Nordic Announces European Marketing Authorization for Ebola Vaccine